The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts <  200 cells/μL: evidence based on a meta-analysis

Current WHO guidelines (2018) recommend screening for cryptococcal antigen (CrAg) in HIV-infected persons with CD4+ T cell counts

Source: BMC Infectious Diseases - June 12, 2020 Category: Infectious Diseases Authors: Yao Li, Xiaojie Huang, Hui Chen, Yuanyuan Qin, Jianhua Hou, Aixin Li, Hao Wu, Xiaofeng Yan and Yaokai Chen Tags: Review Source Type: research